子宫内膜癌阴式子宫切除术的长期结局
该研究利用监测、流行病学和最终结果-医疗保险数据库,纳入2000至2015年接受初次子宫切除术的I-II期子宫内膜癌患者19212例,其中837例(4.6%)接受阴式子宫切除术(TVH)。TVH使用率从2000年的4.5%下降至2015年的2.2%(P<0.0001)。多变量分析显示TVH与癌症特异性生存(HR=0.89;95%CI,0.65-1.22,与腹腔镜子宫切除术相比)无关联,且不负面影响生存。
要点
- TVH使用率从2000年的4.5%下降至2015年的2.2%(P<0.0001)。
- 与65-69岁患者相比,75-79岁(aRR=1.46;95%CI,1.19-1.79)和>80岁(aRR=1.60;95%CI,1.30-1.97)患者更可能接受TVH。
- TVH与腹腔镜子宫切除术相比,癌症特异性生存无关联(HR=0.89;95%CI,0.65-1.22)。
核心结论
- 在美国,I期和II期子宫内膜癌的TVH使用率下降。
- 年龄是TVH实施的最大预测因素。
- TVH不负面影响早期子宫内膜癌女性的生存。
研究设计与样本
- 使用监测、流行病学和最终结果-医疗保险数据库,识别2000至2015年接受初次子宫切除术的I-II期子宫内膜癌女性。
主要发现
- 共识别19212例患者,其中837例(4.6%)接受TVH。
- TVH实施率从2000年的4.5%下降至2015年的2.2%(P<0.0001)。
- 与65-69岁患者相比,75-79岁(aRR=1.46;95%CI,1.19-1.79)和>80岁(aRR=1.60;95%CI,1.30-1.97)患者更可能接受TVH。
- 高级别肿瘤女性接受TVH的可能性更低。
- TAH、TLH和TVH的5年总生存和癌症特异性生存相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total vaginal hysterectomy (TVH) has been proposed as an alternative to laparoscopic (TLH) and abdominal hysterectomy (TAH), particularly for women with medical comorbidities. We examined the use and long-term outcomes of vaginal hysterectomy for women with early-stage endometrial cancer. METHODS: The Surveillance, Epidemiology, and End Results-Medicare database was used to identify women with stage I-II endometrial cancer treated with primary hysterectomy from 2000 to 2015. Multivariable regression models were developed to examine clinical, demographic, and pathologic factors associated with performance of TVH. The association between route of hysterectomy and cancer-specific and overall survival was examined using multivariable Cox proportional hazards models. RESULTS: A total of 19,212 patients including 837 (4.6%) who underwent TVH were identified. Performance of TVH declined from 4.5% in 2000 to 2.2% in 2015 (P < 0.0001). Compared to patients 65-69 years of age, patients 75-79 years old (aRR = 1.46; 95% CI, 1.19-1.79) and those >80 years old (aRR = 1.60; 95% CI, 1.30-1.97) were more likely to undergo TVH. Women with high grade tumors were less likely to undergo TVH. Five-year overall and cancer specific survivals were similar for TAH, TLH, and TVH. In multivariable models, there was no association between TVH and either cancer-specific survival (HR = 0.89; 95% CI, 0.65-1.22) compared to laparoscopic hysterectomy. CONCLUSION: Use of TVH for stage I and II endometrial cancer has decreased in the U.S. Chronologic age is the greatest predictor of performance of TVH. Performance of TVH does not negatively impact survival for women with early-stage endometrial cancer.
引用
- Praiss AM, Huang Y, St Clair CM, et al. Long-term outcomes of vaginal hysterectomy for endometrial cancer. Gynecol Oncol. 2021. PMID: 34763940. doi:10.1016/j.ygyno.2021.10.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。